Literature DB >> 12234655

Cocaine differentially alters behavior and neurochemistry in periadolescent versus adult rats.

Stephanie L Collins1, Sari Izenwasser.   

Abstract

This study examined whether there are differences in the behavioral and neurochemical effects of cocaine in periadolescent rats compared to adult rats. Periadolescent (postnatal days 28-35) and adult rats were injected with cocaine or vehicle for 7 days. Ten days later (day 17), rats either were challenged with cocaine, or dopamine transporter and receptor and serotonin transporter binding were examined. Adult rats became sensitized to the locomotor-activating effects of cocaine and there were increases in dopamine transporter density in the caudate putamen compared to vehicle-treated adult rats. In addition, serotonin transporter densities were increased in the ventromedial caudate putamen, nucleus accumbens shell, and the olfactory tubercle in cocaine-treated adult rats compared to vehicle-treated adult rats. In contrast, periadolescent rats did not show sensitization to cocaine and there was no effect of cocaine on either dopamine or serotonin transporter densities. These findings suggest that there are different neurochemical and behavioral adaptations to repeated cocaine administration in periadolescent versus adult rats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234655     DOI: 10.1016/s0165-3806(02)00471-6

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  49 in total

1.  Effects of periadolescent versus adult cocaine exposure on cocaine conditioned place preference and motor sensitization in mice.

Authors:  Nicole L Schramm-Sapyta; Adeola R Pratt; Danny G Winder
Journal:  Psychopharmacology (Berl)       Date:  2004-01-08       Impact factor: 4.530

Review 2.  The role of the dopamine transporter in cocaine abuse.

Authors:  Sari Izenwasser
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 3.  Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability.

Authors:  Tomas Palomo; R M Kostrzewa; R J Beninger; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

4.  Pretreatment with Δ9-tetrahydrocannabinol (THC) increases cocaine-stimulated activity in adolescent but not adult male rats.

Authors:  Diana Dow-Edwards; Sari Izenwasser
Journal:  Pharmacol Biochem Behav       Date:  2011-09-17       Impact factor: 3.533

Review 5.  Differential effects of psychoactive drugs in adolescents and adults.

Authors:  Sari Izenwasser
Journal:  Crit Rev Neurobiol       Date:  2005

6.  Early adolescents show enhanced acute cocaine-induced locomotor activity in comparison to late adolescent and adult rats.

Authors:  Kimberly A Badanich; Antoniette M Maldonado; Cheryl L Kirstein
Journal:  Dev Psychobiol       Date:  2008-03       Impact factor: 3.038

Review 7.  Neurobiological processes in adolescent addictive disorders.

Authors:  Ty S Schepis; Bryon Adinoff; Uma Rao
Journal:  Am J Addict       Date:  2008 Jan-Feb

8.  Behavioral effects of dopamine receptor inactivation during the adolescent period: age-dependent changes in dorsal striatal D2(High) receptors.

Authors:  Sanders A McDougall; Joseph M Valentine; Ashley E Gonzalez; Danielle E Humphrey; Crystal B Widarma; Cynthia A Crawford
Journal:  Psychopharmacology (Berl)       Date:  2013-11-28       Impact factor: 4.530

9.  Differential effects of methamphetamine and cocaine on conditioned place preference and locomotor activity in adult and adolescent male rats.

Authors:  Elena Zakharova; Giorgia Leoni; Ilona Kichko; Sari Izenwasser
Journal:  Behav Brain Res       Date:  2008-10-18       Impact factor: 3.332

10.  Effects of self-administered cocaine in adolescent and adult male rats on orbitofrontal cortex-related neurocognitive functioning.

Authors:  Roxann C Harvey; Kimberly A Dembro; Kiran Rajagopalan; Michael M Mutebi; Kathleen M Kantak
Journal:  Psychopharmacology (Berl)       Date:  2009-06-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.